Standing the test of time: Outcomes of a decade of prioritizing patients with hepatocellular carcinoma, results of the UNOS natural geographic experiment

Hepatology

Volumn 60, Issue 6, 2014, Pages 1957-1962

  Halazun, Karim J ^a   Patzer, Rachel E ^a   Rana, Abbas A ^b   Verna, Elizabeth C ^c   Griesemer, Adam D ^c   Parsons, Ronald F ^c   Samstein, Benjamin ^c   Guarrera, James V ^c   Kato, Tomoaki ^c   Brown, Robert S ^c   Emond, Jean C ^c  

^a EMORY UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE DISPARITY; HUMAN; LIVER CELL CARCINOMA; LIVER GRAFT; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PREDICTION; AGED; CARCINOMA, HEPATOCELLULAR; EPIDEMIOLOGY; HOSPITAL ADMISSION; LIVER NEOPLASMS; MORTALITY; TRANSPLANTATION; UNITED STATES;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TISSUE AND ORGAN PROCUREMENT; UNITED STATES; WAITING LISTS;

EID: 84911999670     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27272     Document Type: Article

References (13)

1. Ioannou GN, Perkins JD, Carithers RL Jr. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 2008;134:1342-1351.
2. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodgriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004;10:36-41.
3. Yeh H, Smoot E, Schoenfeld DA, Markmann JF. Geographic inequity in access to livers for transplantation. Transplantation 2011;91:479-486.
4. Goldberg D, French B, Abt P, Feng S, Cameron AM. Increasing disparity in waitlist mortality rates with increased model for end-stage liver disease scores for candidates with hepatocellular carcinoma versus candidates without hepatocellular carcinoma. Liver Transpl 2012;18:434-443.
5. Washburn K, Edwards E, Harper A, Freeman R. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transpl 2010;10:1643-1648.
6. Vitale A, Volk ML, Gambato M, Zanus G, D'Amico F, Cararro A, et al. Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. Transpl Proc 2010;42:1194-1196.
7. Schuetz C, Dong N, Smoot E, Elias N, Schoenfeld DA, Markman JF, et al. HCC patients suffer less from geographic differences in organ availability. Am J Transpl 2013;13:2989-2995.
8. Kulik LM, Fisher RA, Rodrigo DR, Brown RS Jr, Friese CE, Shaked A, et al. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transpl 2012;12:2997-3007.
9. Venook AP, Ferrell LD, Roberts JP, Emond J, Frye JW, Ring E, et al. Liver transplantation for hepatocellular carcinoma: results with preoperative chemoembolization. Liver Transpl Surg 1995;1:242-248.
10. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transpl 2005;5:795-804.
11. Morino M, Miglietta C, Grosso M, De Giuli M, Bismuth H. Preoperative chemoembolization for hepatocellular carcinoma. J Surg Oncol Suppl 1993;3:91-93.
12. Roberts JP, Venook A, Kerlan R, Yao F. Hepatocellular carcinoma: ablate and wait versus rapid transplantation. Liver Transpl 2010;16:925-929.
13. Schmitt TM, Kumer SC, Shah N, Argo CK, Northup PG. Liver transplantation for T3 lesions has higher waiting list mortality but similar survival compared to T1 and T2 lesions. Ann Hepatol 2010;9:390-396.